This trial is testing whether a new type of packaging for opioids is more effective in reducing prescribing than the current type of packaging.
4 Primary · 16 Secondary · Reporting Duration: After dispensing all OPPs (approximately 2 years)
Active Control
Experimental Treatment
450 Total Participants · 2 Treatment Groups
Primary Treatment: Opioid Package Prototype (OPP) · No Placebo Group · N/A
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: